Trial intelligence / Profile preview

General anesthesia for morbidly obese patients: rocuronium versus cisatracurium

PACTR201703002147145Completed

Sponsor
Tanta University Hospitals
Start
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of rocuronium and cisatracurium in class III obesity, sponsored by Tanta University Hospitals. Primary endpoint: Quality of relaxation of both drugs. Started Mar 2017; status: completed.

02

Drugs

rocuroniumcisatracurium
03

Conditions

class III obesity

Beyond the preview

Go deeper on PACTR201703002147145.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201703002147145.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call